[Articles] Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial

Data ReadoutpositivePositive

AI Analysis

Summary

The MIST trial demonstrates that minimally invasive coronary artery bypass grafting (MICS CABG) performed by experienced teams improves patient-reported physical recovery at 1 month compared to traditional sternotomy CABG, with sustained safety through 12 months. The findings support consideration of MICS CABG for appropriately selected patients.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

MICS CABG improved patient-reported physical recovery at 1 month compared with sternotomy CABG with no apparent safety penalty through 12 months

Importance:5/10

Sentiment:

0.70

cardiovascularsurgeryCABGclinical_trialMICSrandomized_controlled_trial

Related Companies

$ISCO

Read the original article

Published by The Lancet on July 31, 2026 10:30 PM

Read Original